Cargando…
Challenges in Acute Heart Failure Clinical Management: Optimizing Care Despite Incomplete Evidence and Imperfect Drugs
Acute heart failure is a common condition associated with considerable morbidity, mortality, and cost. However, evidence-based data on treating heart failure in the acute setting are limited, and current individual treatment options have variable efficacy. The healthcare team must often individualiz...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott, Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342318/ https://www.ncbi.nlm.nih.gov/pubmed/25679083 http://dx.doi.org/10.1097/HPC.0000000000000031 |
_version_ | 1782359267626450944 |
---|---|
author | Teichman, Sam L. Maisel, Alan S. Storrow, Alan B. |
author_facet | Teichman, Sam L. Maisel, Alan S. Storrow, Alan B. |
author_sort | Teichman, Sam L. |
collection | PubMed |
description | Acute heart failure is a common condition associated with considerable morbidity, mortality, and cost. However, evidence-based data on treating heart failure in the acute setting are limited, and current individual treatment options have variable efficacy. The healthcare team must often individualize patient care in ways that may extend beyond available clinical guidelines. In this review, we address the question, “How do you do the best you can clinically with incomplete evidence and imperfect drugs?” Expert opinion is provided to supplement guideline-based recommendations and help address the typical challenges that are involved in the management of patients with acute heart failure. Specifically, we discuss 4 key areas that are important in the continuum of patient care: differential diagnosis and risk stratification; choice and implementation of initial therapy; assessment of the adequacy of therapy during hospitalization or observation; and considerations for discharge/transition of care. A case study is presented to highlight the decision-making process throughout each of these areas. Evidence is accumulating that should help guide patients and healthcare providers on a path to better quality of care. |
format | Online Article Text |
id | pubmed-4342318 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Lippincott, Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-43423182015-03-12 Challenges in Acute Heart Failure Clinical Management: Optimizing Care Despite Incomplete Evidence and Imperfect Drugs Teichman, Sam L. Maisel, Alan S. Storrow, Alan B. Crit Pathw Cardiol Review Article Acute heart failure is a common condition associated with considerable morbidity, mortality, and cost. However, evidence-based data on treating heart failure in the acute setting are limited, and current individual treatment options have variable efficacy. The healthcare team must often individualize patient care in ways that may extend beyond available clinical guidelines. In this review, we address the question, “How do you do the best you can clinically with incomplete evidence and imperfect drugs?” Expert opinion is provided to supplement guideline-based recommendations and help address the typical challenges that are involved in the management of patients with acute heart failure. Specifically, we discuss 4 key areas that are important in the continuum of patient care: differential diagnosis and risk stratification; choice and implementation of initial therapy; assessment of the adequacy of therapy during hospitalization or observation; and considerations for discharge/transition of care. A case study is presented to highlight the decision-making process throughout each of these areas. Evidence is accumulating that should help guide patients and healthcare providers on a path to better quality of care. Lippincott, Williams & Wilkins 2015-03 2015-02-17 /pmc/articles/PMC4342318/ /pubmed/25679083 http://dx.doi.org/10.1097/HPC.0000000000000031 Text en Copyright © 2014 by Lippincott Williams # Wilkins. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
spellingShingle | Review Article Teichman, Sam L. Maisel, Alan S. Storrow, Alan B. Challenges in Acute Heart Failure Clinical Management: Optimizing Care Despite Incomplete Evidence and Imperfect Drugs |
title | Challenges in Acute Heart Failure Clinical Management: Optimizing Care Despite Incomplete Evidence and Imperfect Drugs |
title_full | Challenges in Acute Heart Failure Clinical Management: Optimizing Care Despite Incomplete Evidence and Imperfect Drugs |
title_fullStr | Challenges in Acute Heart Failure Clinical Management: Optimizing Care Despite Incomplete Evidence and Imperfect Drugs |
title_full_unstemmed | Challenges in Acute Heart Failure Clinical Management: Optimizing Care Despite Incomplete Evidence and Imperfect Drugs |
title_short | Challenges in Acute Heart Failure Clinical Management: Optimizing Care Despite Incomplete Evidence and Imperfect Drugs |
title_sort | challenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugs |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342318/ https://www.ncbi.nlm.nih.gov/pubmed/25679083 http://dx.doi.org/10.1097/HPC.0000000000000031 |
work_keys_str_mv | AT teichmansaml challengesinacuteheartfailureclinicalmanagementoptimizingcaredespiteincompleteevidenceandimperfectdrugs AT maiselalans challengesinacuteheartfailureclinicalmanagementoptimizingcaredespiteincompleteevidenceandimperfectdrugs AT storrowalanb challengesinacuteheartfailureclinicalmanagementoptimizingcaredespiteincompleteevidenceandimperfectdrugs |